Tracked shipping to South Africa with premium packaging for just R199 

Ship to
South Africa
0

My Account

  • argentina
  • chile
  • colombia
  • españa
  • méxico
  • perú
  • estados unidos
  • internacional

menu

Select your country

Americas

Europe

Rest of the world

portada idiopathic dilated cardiomyopathy: cellular and molecular mechanisms, clinical consequences
Type
Physical Book
Illustrated by
Publisher
Author
Year
2011
Language
English
Pages
405
Format
Paperback
Dimensions
23.4x15.6x2.2 cm
Weight
0.59 kg.
ISBN
3642778933
ISBN13
9783642778933
Categories

idiopathic dilated cardiomyopathy: cellular and molecular mechanisms, clinical consequences

Hans-Reiner Figulla (Illustrated by) · Reinhard Kandolf (Illustrated by) · Bruce McManus (Illustrated by) · Springer · Paperback

idiopathic dilated cardiomyopathy: cellular and molecular mechanisms, clinical consequences - Figulla, Hans-Reiner ; Kandolf, Reinhard ; McManus, Bruce

Cheaper New Book Imported to South Africa
Delivery: 20 Oct - 28 Oct Shipping: 15 to 16 business days.
R 1,970
Faster New Book Imported to South Africa
Delivery: 06 Oct - 14 Oct Shipping: 5 to 6 business days.
R 2,408
R 1,970

Choose the list to add your product or create one New List

Go to My Wishlists
Calculate shipping cost

Synopsis "idiopathic dilated cardiomyopathy: cellular and molecular mechanisms, clinical consequences"

Idiopathic cardiomyopathy has been categorized for over 10 years by the World Health Organization as dilated, hypertrophic, or restrictive. These categories have somewhat vague boundaries; however, idiopathic dilated cardiomyopathy (IDC) finds its general definition from unexplained four-chamber dilatation, prominent systolic dysfunction with depressed ejection fraction, a marked increase in total myocardial mass without wall thickening, myocyte hypertrophy and nuclear polyploidy, rarity of frank myocardial scars, but increased interstitial connective tissue and myocyte atrophy, all in the setting of anatomically normal heart valves and coronary arteries. Mural thrombi within cardiac chambers and atrioventricular valve regurgitation are common secondary con comitants. Myocardial inflammation is rare, but immunological abnormalities have been suggested. Ultrastructural features in clude increased mitochondrial numbers, lipid deposits, and myo fibrillar loss. Progressive pump failure with or without rhythm disturbances typically leads to ever-intensified medical therapies, and ultimately to transplantation or early death. The need for better understanding of IDC is represented by incidence rates varying from 5 to 8/100000 population across several populations, 10 000-20000 IDC deaths annually in the United States, and the generally increasing prevalence of the disease. More than 50% of heart transplant recipients have IDC as their primary myocardial disease. The half-life of patient sur vival without transplantation is generally less than 5 years. Treat ment with antiarrhythmics, calcium channel blockers, -adrenergic blockers, and angiotensin-converting enzyme inhibitors is being evaluated in clinical trials, but the role of such treatments in the pathobiology of progressive disease is unclear."

Customers reviews

More customer reviews
  • 0% (0)
  • 0% (0)
  • 0% (0)
  • 0% (0)
  • 0% (0)

Frequently Asked Questions about the Book

Is the book original?

All books in our catalog are Original.

In what language is the book written?

The book is written in English.

What is the format of this book?

The binding of this edition is Paperback.

Questions and Answers about the Book

Do you have a question about the book? Login to be able to add your own question.

Opinions about Bookdelivery

More customer reviews